688 related articles for article (PubMed ID: 12697889)
1. Cost of migration: invasion of malignant gliomas and implications for treatment.
Giese A; Bjerkvig R; Berens ME; Westphal M
J Clin Oncol; 2003 Apr; 21(8):1624-36. PubMed ID: 12697889
[TBL] [Abstract][Full Text] [Related]
2. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
Lefranc F; Brotchi J; Kiss R
J Clin Oncol; 2005 Apr; 23(10):2411-22. PubMed ID: 15800333
[TBL] [Abstract][Full Text] [Related]
3. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
[TBL] [Abstract][Full Text] [Related]
4. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
6. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways triggering glioma cell invasion.
Salhia B; Tran NL; Symons M; Winkles JA; Rutka JT; Berens ME
Expert Rev Mol Diagn; 2006 Jul; 6(4):613-26. PubMed ID: 16824034
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
10. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.
Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C
J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330
[TBL] [Abstract][Full Text] [Related]
11. Biology and treatment of malignant glioma.
Prados MD; Levin V
Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
[TBL] [Abstract][Full Text] [Related]
12. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus.
Bates DC; Sin WC; Aftab Q; Naus CC
Glia; 2007 Nov; 55(15):1554-64. PubMed ID: 17823969
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a secreted chemorepellent that directs glioma cell invasion.
Werbowetski T; Bjerkvig R; Del Maestro RF
J Neurobiol; 2004 Jul; 60(1):71-88. PubMed ID: 15188274
[TBL] [Abstract][Full Text] [Related]
14. Correlating velocity patterns with spatial dynamics in glioma cell migration.
Deisboeck TS; Demuth T; Mansury Y
Acta Biotheor; 2005; 53(3):181-90. PubMed ID: 16329007
[TBL] [Abstract][Full Text] [Related]
15. Identification of intrinsic in vitro cellular mechanisms for glioma invasion.
Tektonidis M; Hatzikirou H; Chauvière A; Simon M; Schaller K; Deutsch A
J Theor Biol; 2011 Oct; 287():131-47. PubMed ID: 21816160
[TBL] [Abstract][Full Text] [Related]
16. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
17. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
Frosina G
Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
[TBL] [Abstract][Full Text] [Related]
18. Molecular tools: biology, prognosis, and therapeutic triage.
Fischer I; Aldape K
Neuroimaging Clin N Am; 2010 Aug; 20(3):273-82. PubMed ID: 20708546
[TBL] [Abstract][Full Text] [Related]
19. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
[TBL] [Abstract][Full Text] [Related]
20. [Oncolytic viruses in the therapy of gliomas].
Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
